Whereas tuberculosis is a recommended indication for initiation of HAART at any CD4 count, the WHO guidelines state that “there are limited data on the initiation of ART in patients with TB and CD4 counts of >350 cells/mm3” [62]. The gene discussed is CD4; the disease is tuberculosis.